Reply letter to: Inhibition of SARS‐CoV‐2 replication using calcineurin inhibitors: Are concentrations required clinically achievable? by Gálvez‐Romero, J. L., Deveaux‐Homs, J., Real‐Ramírez, F. A., Palmeros‐Rojas, O., Pedraza‐Sánchez, S.

Request full text

Cyclosporine A plus low‐dose steroid treatment in COVID‐19 improves clinical outcomes in patients with moderate to severe disease: A pilot study by Gálvez‐Romero, J. L., Palmeros‐Rojas, O., Real‐Ramírez, F. A., Sánchez‐Romero, S., Tome‐Maxil, R., Ramírez‐Sandoval, M. P., Olivos‐Rodríguez, R., Flores‐Encarnación, S. E., Cabrera‐Estrada, A. A., Ávila‐Morales, J., Cortés‐Sánchez, V., Sarmiento‐Padilla, G., Tezmol‐Ramírez, S. E., Aparicio‐Hernández, D., Urbina‐Sánchez, M. I., Gómez‐Pluma, M. Á., Cisneros‐Méndez, S., Rodríguez‐Rivas, D. I., Reyes‐Inurrigarro, S., Cortés‐Díaz, G., Cruz‐Delgado, C., Navarro‐González, J., Deveaux‐Homs, J., Pedraza‐Sánchez, S.

Request full text